Delivery Order SPE2DB22D1106-SPE2DB24FEGG7
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension. The delivery order has a total ceiling value of $14,212.64 and an ultimate completion date of September 26, 2024. The contract is a firm-fixed-price arrangement, and no set-aside designation was used. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Prilosec DR 10 mg suspension (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,874.39 under a firm fixed-price arrangement, with an ultimate completion date of November 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567908468 - Prilosec DR 10 MG Suspension 30S, a pharmaceutical product. The contract has a ceiling value of $4,039.89 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Prilosec DR 10 mg Suspension, a prescription medication, with a ceiling value of $10,532.34 and a performance period through July 10, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Prilosec DR 10 mg suspension medication in 30-count packages. The $5,973.37 firm-fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DB22D1106|SPE2DB24FEHP3) worth $2,243.05 by the Defense Logistics Agency (DLA) Troop Support Medical to provide Prilosec DR 10 mg suspension medication. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prilosec DR 2.5 mg suspension (30-count units) with a ceiling value of $1,155.57. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 11, 2025. No set-aside designation was utilized for this...
- This federal contract award is for the delivery of Prilosec DR 10 mg suspension medication, with a ceiling value of $15,854.94. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as Amerisourcebergen. The contract is a delivery order type with a firm fixed price, and has an ultimate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEGG7Delivery Order
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $2,685.17, is for the provision of Prilosec DR 10 mg suspension medication to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical. This specific delivery order falls under that IDC. No set-aside designations were used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/21/24 |